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ABSTRACT  
The -13910C>T polymorphism (rs4988235) upstream from the lactase (LCT) gene, strongly 
associated with lactase persistence (LP) in Europeans, is emerging as a new candidate for obesity.  
Our aim was to analyze the association of rs4988235 with obesity-related variables and its 
modulation by dairy product intake in an elderly population. We studied 940 White subjects (aged 
67+/-7 years) from the Spanish Mediterranean population. Dairy product consumption was 
assessed by a validated questionnaire. Anthropometric variables were directly measured, and 
metabolic-syndrome (MetS)-related variables were obtained. Prevalence of the CC genotype 
(38.0%) [lactase non-persistent (LNP)] was higher than in northern Europe. CT and TT were 
45.7% and 16.3%, respectively.  The CC genotype was not associated with lower milk or dairy 
product consumption in the whole population. Only in women was dairy intake significantly lower 
in CC subjects. The most important association was obtained with anthropometric measurements. 
CC individuals had lower weight (P=0.032), lower BMI (29.7+/-4.2 vs 30.6+/-4.2 Kg/m2;P=0.003) 
and lower waist circumference (101.1+/-11.8 vs 103.5+/-11.5 cm;P=0.005) than T-allele carriers. 
Obesity risk was also significantly higher in T-allele carriers than in CC individuals (OR:1.38; 
95% CI:1.05-1.81; P=0.01), and remained significant after adjustment for sex, age, diabetes, 
physical activity and energy intake. Dairy lactose intake modulated these associations, being 
higher with higher lactose intake. No significant associations with lipids, glucose or blood pressure 
were obtained after adjustment for BMI. In conclusion, despite not finding marked differences in 
dairy product consumption, the rs4988235 polymorphism was strongly associated with obesity and 
modulated by lactose intake in this Mediterranean population. 
 
Key words: Lactase, obesity, gene, dairy products, lactose, metabolic syndrome, Mediterranean
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INTRODUCTION 
The association of dairy food consumption with obesity and other cardiovascular risk 
factors has been investigated in several studies, but with contradictory results (1-6). A beneficial 
effect of dairy consumption on the incidence of various metabolic syndrome components 
(including obesity, glucose intolerance, hypertension, and dyslipidemia) was reported by Pereira et 
al (1) in the CARDIA study and replicated in some (2-4), but not all (5,6) subsequent studies. 
Some meta-analyses carried out for this purpose reflect the inconsistency of results and underline 
the need to analyse the different factors involved in greater depth (7-9). One of the potential 
factors that may affect the quantity of milk consumed as well as the effects of dairy products on 
obesity and obesity-related variables in adults is lactose intolerance or lactase non-persistence 
(LNP). Lactose intolerance is the syndrome of diarrhoea, abdominal pain or flatulence, occurring 
after lactose ingestion (10). These symptoms, caused by a decreased ability to hydrolyze lactose 
due to a deficiency in the enzyme lactase, may have an influence in the amount of dairy product 
consumed. On the other hand, if there is no restriction of dairy products in LNP subjects, the 
undigested lactose may have several metabolic effects that may be related to obesity. 
Lactase is coded by the lactase gene (LCT), and LCT activity remains high until weaning, 
then it fades away in most of the adult population (adult-type hypolactasia or LNP). A single 
nucleotide polymorphism (SNP) (rs4988235), located at -13910 bp upstream from the LCT gene (-
13910C > T) within intron 13 of the adjacent minichromosome maintenance 6 (MCM6) gene was 
found to be associated with LNP (11). Various studies (11-13) have demonstrated that the -
13910C > T SNP is functional and is associated with changes in LCT gene expression.  Individuals 
homozygous for the C allele (LNP) have almost undetectable levels of intestinal lactase production 
compared to TC or TT individuals [lactase persistent (LP), following a codominant model] (11). 
Pohl et al (14) found an excellent agreement between the lactose hydrogen test (10) and the 
Page 3 of 27
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901
Obesity
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 4 
genetic test based on this SNP for LNP in Europeans. The frequency of LP is high in northern 
European populations, decreases across southern Europe and more than half of the world’s 
population is LNP (15). Although some studies have associated the CC genotype with a lower 
consumption of milk (16-18), this association is not always observed (19-21). 
Interestingly, the LCT gene is emerging as a new candidate gene related with obesity and 
other anthropometric measurements. Hence, in a recent Genome-Wide Association Study (GWAs) 
carried out by CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology), the 
Consortium (22) found a strong association between various SNPs in the LCT gene and waist 
circumference. Likewise, Kettunen et al (23), undertook a meta-analysis on eight European 
cohorts (in which the Mediterranean population was not included) finding a strong association 
between the LP variant (T allele, rs4988235) and higher body mass index (BMI). However, none 
of the published studies has analyzed the joint influence of the LP genotype and dairy product 
consumption on obesity. Therefore, our aim was to study the association of the -13910C>T SNP 
with obesity and obesity-related variables as well as its modulation by lactose intake in an elderly 
Mediterranean population. 
 
MATERIAL AND METHODS 
Subjects and study design 
We studied 940 unrelated White individuals (338 men and 602 women), mean age 67.3+/-
6.5 years, who participated in the PREDIMED (Prevención con Dieta MEDiterránea) study, were 
consecutively recruited in the Valencia Region (on the East Mediterranean coast of Spain) from 
October 2003 to December 2008 and had the -13910C>T SNP genotype determined. All 
participants gave their informed consent. The ethics committee of the University of Valencia 
approved the study. Details of this study have been previously reported (24). Briefly, high 
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cardiovascular risk subjects were selected by physicians in Primary Care Centers participating in 
the study. Eligible subjects were community-dwelling people (55-80 years of age for men; 60-80 
years of age for women) who fulfilled at least one of two criteria: type 2 diabetes; 3 or more 
cardiovascular risk factors (current smoking, hypertension, dyslipidemia, overweight, or a family 
history of premature cardiovascular disease).  
Demographic, anthropometric and clinical measurements 
The baseline examination included assessment of standard socio-demographic factors, 
clinical, biochemical and lifestyle variables, as previously detailed (24). Anthropometric variables 
were directly measured by trained nurses by standard techniques at baseline (24). Height and 
weight were measured with light clothing and no shoes. Obesity was defined as BMI>=30kg/m2. 
Waist circumference was measured midway between the lowest rib and the iliac crest using an 
anthropometric tape. Trained personnel measured blood pressure with a validated semi-automatic 
sphygmomanometer (Omron HEM-705CP, The Netherlands) in a seated position after a 5-min 
rest. Physical activity was estimated by the Minnesota Leisure Time Physical Activity as 
previously reported (24). Blood samples were obtained for each participant after an overnight fast 
and were frozen at -80ºC. Fasting glucose, total cholesterol, triglycerides, HDL-C and LDL-C 
were determined as previously reported (24). The metabolic syndrome was defined according to 
updated ATP III criteria (25), which require that 3 or more of the following conditions be met: 
abdominal obesity (waist circumference >102 cm in men and >88 cm in women), 
hypertriglyceridemia (triglycerides level 150 mg/dL), low HDL cholesterol level (<40 mg/dL in 
men and <50 mg/dL in women), elevated fasting blood glucose level (100 mg/dL), and elevated 
blood pressure (systolic 130 mm Hg, diastolic 85 mm Hg, or taking antihypertensive medication). 
Participants who were being treated with antidiabetic, antihypertensive, or triglyceride-lowering 
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 6 
medications were considered to be diabetic, hypertensive, or hypertriglyceridemic, respectively. 
Dietary measurements 
Food consumption was determined by a validated (26) semi-quantitative 137-item food 
frequency questionnaire (FFQ). Energy and nutrient intake were calculated from Spanish food 
composition tables (27). Lactose content was not available in the Spanish tables and so foreign 
food composition tables were used (Fineli Food Composition Database, Finland, release 2010). 
The questionnaire was based on the typical portion sizes that were multiplied by the consumption 
frequency for each food.  Information about dairy products was assessed in fifteen items of the 
semi-quantitative FFQ (whole-fat milk, partially skimmed milk, skimmed milk, condensed milk, 
whipped cream, yoghurt, skimmed yoghurt, milkshake, ricotta cheese or junket, petit Suisse 
cheese, spreadable cheese wedges, cottage cheese, other cheese, custard, and ice cream). We 
calculated total dairy products intake (in g/d) for each individual on the basis of the type and 
amount consumed. 
DNA extraction and genotyping 
Genomic DNA was isolated from blood. The rs4988235 LCT SNP was determined using a 
7900HT Sequence Detection system (Applied Biosystems) and a customized fluorescent allelic 
discrimination TaqMan assay by standard procedures. For quality control purposes, 50% of 
randomly selected samples were also genotyped by restriction fragment length polymorphism 
analysis. Concordance between techniques was higher than 95%. Discrepant samples were 
sequenced. Information on probes and polymerase chain reaction conditions for genotyped single 
nucleotide polymorphisms can be obtained from the authors upon request. 
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Statistical analysis 
 χ
2
 tests were used to test differences in percentages. Taking into account that the 
genetically defined LP is considered to follow a dominant model, CT and TT subjects (LP) were 
grouped and compared with CC subjects for the statistical analysis after having checked that this 
dominant model is observed in this Mediterranean population. We applied the t tests to compare 
crude means for normally distributed variables. Alcohol and dairy product consumption did not 
follow a normal distribution and we applied the non-parametric Mann-Whitney U test. For 
continuous anthropometric variables, multivariate adjustment was carried out by linear regression 
analysis. Model were adjusted for sex, age (as continuous), diabetes, total energy intake (as 
continuous) and physical activity (as continuous). Additional adjustment for dairy product 
consumption was also done. Multivariate adjustment of plasma lipids, fasting glucose and blood 
pressure was also carried out by linear regression. Regression coefficients and adjusted means for 
each predictor were estimated from the multivariate models. Regression models with interaction 
terms and as well as stratified analysis were applied to test the homogeneity of effects by gender 
and lactose intake. Logistic regression models were fitted to estimate the odds ratio (OR) and 95% 
confidence interval (CI) of obesity and obesity-related variables associated with the LP genotype 
compared with LNP. Analyses were performed using the SPSS statistical software, version 17.0 
(SPSS Inc, Chicago, Illinois). 
 
RESULTS 
 Table 1 shows general characteristics of the study subjects by gender. Prevalence of 
obesity, diabetes and metabolic syndrome was high given that this study involved a population that 
was selected for being elderly and with a high cardiovascular risk. Total dairy product 
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 8 
consumption was higher in women than in men (395.2+/-229.6 g/d vs 322.3+/-193.9 g/d, 
respectively; P<0.001). Men consumed a greater amount of whole-fat milk whereas women 
consumed more skimmed milk and skimmed yoghurt, and there were no significant differences 
between men and women in the amount of whole-fat yoghurt consumed. Likewise, total cheese 
intake did not differ between men and women. The amount of lactose intake derived from dairy 
products was also significantly higher in women than men (P=0.01). However, there were no 
significant differences in the percentage of men and women who claim never to consume milk 
(14.2% vs 14%; P=0.994).  
 Prevalence of the LCT -13910 C>T genotypes were: CC (LNP) 38.0% (n=357), CT 45.7% 
(n=430) and TT 16.3% (n=153). Carriers of the T allele were the genetically determined LP 
subjects. This distribution was in Hardy-Weinberg equilibrium (P=0.221) and did not differ 
between men and women (P=0.577).   
Association between the rs4988235 SNP and dairy product intake 
 Table 2 shows mean intake of milk and dairy products (total and by gender) depending on 
the LCT -13910 C>T genotypes.  The results are shown grouping the T carriers together (LP) and 
comparing them with CC subjects (LNP). Total energy intake did not differ between CC and 
subjects carrying the T- allele. Likewise, we did not find significant differences in physical activity 
depending on the LCT genotype (not shown). On analysing the results for men and women jointly, 
it is observed that although diary product consumption tended to be lower in CC subjects, the 
differences did not reach statistical significance.  Neither was the total consumption of milk or the 
contribution of lactose or calcium through dairy products lower. Statistically significant 
differences were only reached in the consumption of skimmed yoghurt, which was lower in CC 
subjects.  
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 9 
 On analysing the results per gender, it can be observed that in men the differences in milk 
and dairy product intake depending on genotype were minimal and did not reach statistical 
significance for any comparison. In women, these differences were more accentuated; reaching 
statistical significance in the consumption of skimmed yoghurt (lower in CC subjects) and when 
the consumption of skimmed yoghurt, skimmed milk and partially skimmed milk were analyzed 
together (265.1 +/- 207.9 g/d vs 317.6+/-239.2 g/d in CC vs CT+TT; P=0.014). Likewise, the total 
consumption of dairy products also reached statistically significant differences in women 
depending on the LCT genotype (P=0.045). No significant differences of lactose intake were 
found. 
Association between the rs4988235 SNP with anthropometric variables 
 We observed that the LCT -13910 C>T SNP presented a strong association with 
anthropometric measures (Table 3). CC individuals, although they do not differ in height from the 
other genotypes, had significantly less weight, a lower BMI and less waist-circumference than T-
allele carriers. These differences remained statistically significant when the models were adjusted 
for gender and age, and even after additional adjustment for diabetes, physical activity and total 
energy intake. These associations were homogeneous by gender, and both in men and women CC 
subjects have lower means of anthropometric measurements than T-allele carriers (P for 
interaction LCT genotype x gender were 0.738, 0.872 and 0.942 for weight, BMI and waist 
circumference, respectively). 
 Next, we analyzed the association of the LCT -13910 C>T SNP with obesity (Table 3). 
Considering CC individuals as the reference category, we observed that T-allele carriers have a 
greater risk (OR) of obesity, both unadjusted (OR: 1.39; 95% CI: 1.07-1.82; P=0.014) and after 
adjustment for gender, age, diabetes, physical activity and total energy intake (OR: 1.37; 95% CI: 
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1.03-1.81; P=0.029). Homogeneity by gender was also observed between men and women in this 
association (P for interaction LCT x gender =0.826). Subsequent adjustments for dairy product 
intake do not modify the statistical significance of the associations of the LCT -13910 C>T SNP 
with the anthropometric variables (not shown).   
Modulation of the association between the rs4988235 SNP with anthropometric variables by 
lactose intake 
 Considering that CC subjects may tolerate low amounts of lactose intake without 
gastrointestinal symptoms, we hypothesized that dairy lactose intake may modulate the effects of 
the LCT -13910 C>T SNP on anthropometric variables. We first tested the interaction effect 
between the LCT -13910 C>T SNP and dairy lactose intake as continuous. Taking into account 
dairy lactose intake was not normally distributed, eight identified outliers (corresponding to 8 
TC+TT subjects with lactose intake higher that 50g/d) were removed to improve normality for this 
linear regression analysis.  We found a statistically significant interaction term between lactose 
intake and the LCT -13910 C>T SNP in determining waist circumference (P=0.044 after 
adjustment for sex, age, diabetes, total energy intake and physical activity). According to this 
interaction, a higher dairy lactose intake increased the differences in waist-circumference between 
CC and CT+TT individuals (Figure 1 A). We also tested this modulation by lactose intake as a 
categorical variable. Three categories of lactose intake based on habitual milk consumption 
equivalence were considered (Figure 1B). No differences in the LCT -13910 C>T genotype 
distribution among categories (low, intermediate and high) of lactose intake (P=0.518) were 
observed. When lactose intake was low [less than one small cup per day (<=8 g lactose/d); 20% of 
the population], we did not find significant differences in waist-circumference between CC and T-
allele carriers (P=0.808). When lactose intake was intermediate [between 1 and 2 small or large 
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cups of milk per day (8-24 g lactose/d); 50% of the population], significant differences in waist 
circumference between LCT genotypes were detected (P=0.012). These differences increased in 
magnitude when higher intakes of lactose were observed [more than 2 large cups of milk per day 
(>24 g lactose/d); 30% of the population]. 
 In terms of obesity risk, in subjects with a low lactose intake (<=8 g/d) we did not find 
significant association between the LCT -13910 C>T SNP and obesity in the crude model 
(OR=1.03, 95%CI: 0.55-1.91; P=0.910) or in the model adjusted for sex, age, diabetes, physical 
activity and total energy intake (OR=1.05, 95%CI: 0.54-2.01; P=0.891). However, when lactose 
intake was higher (>8 g/d), we did observe a significant association of the CT+TT genotype with 
higher obesity risk (OR: 1.50, 95%CI: 1.10-2.03; P=0.012 in the crude model and OR: 1.44, 
95%CI: 1.05-1.96; P=0.022 in the model adjusted for sex, age, diabetes, physical activity and total 
energy intake). 
Association between the rs4988235 SNP with the metabolic syndrome related variables 
 Finally, we studied the association of the LCT SNP with biochemical parameters (fasting 
glucose, and plasma lipids), and blood pressure (Table 4) and observed that, after adjustment for 
BMI, there were no statistically significant differences in total cholesterol, LDL-C, HDL-C, TG, 
fasting glucose concentrations or blood pressure between CC subjects and T-allele carriers. When 
we analyzed the association of the LCT SNP with the Metabolic syndrome, taking CC individuals 
as the reference category, although the magnitude of the OR in T-allele carriers was greater than 1, 
it did not reach statistical significance, either adjusted for gender and age (OR: 1.26; 95%CI: 0.95-
1.68; P=0.114) or after additional adjustment for physical activity and total energy intake (OR: 
1.24; 95%CI: 0.92-1.67; P=0.164). When we tested the potential modulation by lactose intake, we 
found that in subjects with a low lactose intake (<=8 g/d), the LCT SNP was not associated with 
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the metabolic syndrome (OR adjusted for sex, age, physical activity and energy intake: 0.98, 
95%CI: 0.49-1.96; P=0.955), this association being statistically significant in subjects with lactose 
intake higher than 8 g/d (OR adjusted for sex, age, physical activity and energy intake: 1.40, 
95%CI: 1.02-1.90; P=0.040). However, this association was mainly mediated by abdominal 
obesity. It was the only component of the metabolic syndrome that was significantly associated 
with the LCT polymorphism. 
 
DISCUSSION 
In this study carried out on a high cardiovascular risk Mediterranean population, we have 
detected a high prevalence of CC individuals (LNP) in contrast to that found in northern European 
populations, where the opposite situation is found (15,28). Although the effect of the LCT 
polymorphism on the differences of milk and dairy product consumption was not very high in the 
population as a whole, the association that we have found with anthropometric measurements is 
particularly relevant. In this Mediterranean population, CC individuals had significantly lower 
BMI, lesser waist circumference and lower risk of obesity than T-allele carriers even after 
adjustment for sex, age, diabetes, physical activity and total energy intake. Moreover, we reported 
for the first time that the association between the -13910C > T LCT SNP and anthropometric 
variables is modulated by dairy lactose intake. These observations are in line with the results 
obtained in a recently published meta-analysis (23) that reported novel evidence of association 
between the -13910C>T LCT polymorphism and BMI (P = 7.9x10-5) in 31,720 European 
individuals. Eight cohorts were included, five of which were of Finnish origin (with a high milk 
intake), and the others from Holland and England, without including a Mediterranean population. 
They observed that the CC genotype was associated with decreased BMI compared to CT/TT 
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genotypes in the meta-analysis, and that this effect was observed in the same direction for both 
men and women. They also observed that this effect was due to the influence of the genotype on 
weight and not on height. Moreover, they discarded population stratification as being responsible 
for these effects. In our study, the probability of the influence of population stratification is very 
low, as we carried it out on White subjects recruited in a single region of Spain with a 
homogenous ethnic background. Another study undertaken on a sample of 944 postmenopausal 
Spanish women recruited in another Spanish region (Catalonia) aimed to investigate the 
association of the LCT SNP with osteoporosis phenotypes obtained a similar frequency of -
13910C>T LCT genotypes (29). These researchers also found a significant association of the LCT 
SNP with weight. Hence, TT women were 1.91 kg heavier than CT+CC women, adding 
consistency to the association found in our study. However, in that same study, the authors did not 
analyse the possible differences in waist circumference or obesity risk associated with the LCT 
SNP, our study being the first to report such associations in a Mediterranean population.   
Furthermore, our results were also the first to replicate the observations of the CHARGE 
Consortium, where strong associations were found between various SNPs in the LCT gene and 
waist-circumference (22). In line with those observations, a study carried out by Almon et al on 
551 individuals of the general population of the Canary Islands (30), found that the prevalence of 
central obesity was higher in CT+TT (62%) individuals than in CC individuals (55.9%). However, 
those differences did not reach statistical significance possibly due to a smaller sample size.   
Nevertheless, what they did observe was a greater risk of metabolic syndrome in CT+TT 
individuals than in CC individuals (OR: 1.56; 95%CI: 1.06–2.31). In our study, carried out on a 
Mediterranean population, and despite the tendency of the association with metabolic syndrome 
being similar to that observed in the Canary islands, our results did not reach statistical 
significance in the whole population, given that we observed the effects of the LCT SNP mainly on 
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anthropometric measurements and not on lipid concentrations, glucose or blood pressure. 
However, in subgroup analysis, we observed a significant association between the metabolic 
syndrome and the LCT SNP in subjects with lactose intake higher than 8g/d. Considering that milk 
consumption was higher in the Canary Islands than in our population, both results are in 
agreement. On the other hand, the differences observed between these two studies may be due to 
the different ages of the population and associated risk factors. Thus, although in the study carried 
out in the Canary Islands (mean age 45+/-15 years) CC individuals were found to consume less 
milk than CT+TT  individuals (246 vs 300 g/d; P<0.05), our study found no significant differences 
in the amount of total milk consumed depending on the LCT SNP. Possibly, on dealing with an 
elderly population in which calcium requirements are greater to minimize osteoporosis, medical 
advice recommending higher milk consumption may have a greater influence, that 
recommendation offsetting the genetic influence.  
Other studies that have analysed the influence of the LCT SNP on milk and dairy product 
consumption have also found differing associations depending on the age and gender of the 
population analysed (16-21,31,32). In general, it seems that the influence of the LCT genotype on 
dairy consumption is higher in women than in men. So, for example, in the study carried out by 
Laaksonen et al in Finland (17), it was observed that in females with the CC genotype, milk and 
milk product consumption was lowest from the age of 6 years to adulthood with higher differences 
than those observed in males. In our study, CC women presented a lower total consumption of 
low-fat milk and yoghurt and than T-carriers, as well as a lower total dairy product consumption, 
which was not observed in men.  One possible explanation could be that females and males differ 
in their sensitivity to gastrointestinal symptoms caused by maldigested lactose, being stronger in 
women (33).  
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Another possible explanation could be that as men consume less milk than women, the 
amount of lactose does not pose a problem even for the LNP, as it has been reported that 
gastrointestinal symptoms of intolerance to lactose are not important until consuming amounts 
greater than 12 g of lactose/d (approximately 250 ml of milk) (34). Other authors indicate that 
lactose maldigesters may be able to tolerate foods containing 6 g lactose or less per serving, such 
as hard cheeses and small servings (120 mL or less) of milk (35). In our study we did not found 
differences in the prevalence of the LP or LNP genotypes among the three categories of lactose 
intake considered [low (<=8g/d, intermediate (8-24 g/d) and high (>24 g/d)]. The symptoms of 
lactose intolerance result from bacterial fermentation of undigested lactose in the colon (10). 
Therefore, the same amount of lactose ingested can lead to different gastrointestinal effects in LNP 
and LP subjects and these effects be related to the observed obesity phenotypes. In addition to 
differences in abdominal pain, bloating, or diarrhoea that may be related to less weight (10), 
various studies have shown differences in the microbial composition of fecal samples of the LP 
and LNP individuals (36,37) that may relate to obesity even in the absence of gastrointestinal 
symptoms. For example, Szilagyi et al (37), observed that lactose maldigesters had differences in 
bifidobacteria and lactobacilli counts compared with lactose digesters. Bearing in mind that recent 
studies have shown differences between the gut microbiota in obese and non-obese individuals 
(38-40), changes in the gut microbiota in LNP compared with LP subjects may be involved in the 
lower risk of obesity observed in CC individuals, due to differing lactose fermentation capacity 
and the subsequent multiple effects. This hypothesis, as well as the identification of additional 
mechanisms to explain the association of the -13910C>T LCT SNP with obesity-related variables, 
requires further studies in order to substantiate it. Supporting this hypothesis is our observation of 
a possible greater effect of the LCT SNP on anthropometric measurements when the amounts of 
lactose consumed are greater.  When dairy lactose intake was low (<=8 g/d), we did not find 
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significant differences in waist circumference or obesity risk between CC and T-allele carriers. 
However, significant differences in were found with higher lactose intake. This is the first time 
that a modulation by the amount of lactose intake of the effects of the -13910C>T LCT SNP on 
obesity is reported and requires replication in other populations. Moreover, our results suggest that 
some of the controversial results obtained in previous studies investigating the effect of dairy 
product consumption on obesity-related variables, may be explained by the potential 
heterogeneous effects of these products on LNP and LP individuals in those cohorts. Therefore, 
genotyping of the -13910C>T LCT SNP in these studies would be of interest to clarify the results. 
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Table 1: Demographic, anthropometric, dietary and genetics characteristics
of the studied subjects
Mean   (SD) Mean   (SD)
Age (years)* 66 (7) 67 (6)
Weight (Kg)* 81.2 (12.0) 73.4 (11.0)
Heigh (m)* 1.66 (0.06) 1.55 (0.06)
Waist circumference (cm)* 104 (12) 102 (12)
BMI (Kg/m2)* 29.5 (3.8) 30.7 (4.4)
Physical activity (kcal/d)* 220 (217) 136 (126)
Total energy intake (kcal/d)* 2384 (669) 2117 (614)
Total fat intake (% energy) 38.7 (7.6) 39.1 (6.9)
Carbohydrates (% energy) 41.8 (7.9) 42.6 (6.9)
Proteins (% energy)* 16.3 (2.7) 17.4 (2.7)
Alcohol (g/d)* 11.7 (14.9) 2.6 (4.8)
Total dairy products (g/d)* 322.3 (193.9) 395.2 (229.6)
Whole-fat milk (g/d)* 43.1 (123.1) 35.3 (120.3)
Partially skimmed milk (g/d) 103.5 (153.1) 127.4 (188.7)
Skimmed milk (g/d)* 77.3 (145.0) 114.8 (191.0)
Whole-fat yoghurt (g/d) 21.9 (54.2) 21.0 (55.5)
Skimmed yoghurt (g/d)* 36.9 (64.4) 56.0 (79.9)
Total cheese (g/d) 30.8 (23.2) 34.3 (27.5)
Lactose (g/d)* 12.9 (8.8) 15.9 (10.4)
Nonconsumers of milk (%)
Current smokers (%)*
Obesity (%)*
Diabetes (%)*
Metabolic syndrome (%)*
LCT (-13910C>T) genotype (%)
    CC (LNP)
    CT (LP)
    TT (LP)
SD: Standard deviation
The metabolic syndrome was defined according to updated ATP III criteria
*: Statistically significant differences between men and women (Student´s t test for
continuous variables with normal distribution or the non-parametric Mann-Whitney U
test for dairy products, alcohol and physical activity. Chi square tests for categorical
variables)
LNP: Lactase non-persistence; LP: Lactase persistence
42.4 53.5
Men (n=338) Women (n=602)
27.8 4.1
14.014.2
54.4 41.9
53.5 66.8
17.2 15.8
39.3 37.2
43.5 47.0
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Table 2: Association of the LCT rs4988235 polymorphism with dairy product consumption in the elderly Mediterranean population
P P P
Mean   (SD) Mean   (SD) Mean   (SD) Mean   (SD) Mean   (SD) Mean   (SD)
Age (years) 67.5 (6.1) 66.8 (6.1) 0.075 66.9 (6.4) 66.2 (7.0) 0.472 67.8 (6.0) 67.1 (5.5) 0.153
Total energy intake (kcal/d) 2228.2 (646.3) 2204.4 (648.1) 0.599 2404.6 (683.9) 2370.8 (661.3) 0.617 2121.9 (599.7) 2113.9 (623.4) 0.882
Total dairy products (g/d) 354.1 (198.6) 377.8 (231.8) 0.124 330.2 (187.0) 317.1 (198.5) 0.387 368.5 (204.3) 410.7 (242.0) 0.045
Whole-fat milk (g/d) 46.1 (134.7) 33.2 (112.3) 0.068 45.4 (113.7) 41.6 (129.0) 0.440 46.6 (146.1) 28.6 (101.9) 0.088
Partially skimmed milk (g/d) 112.2 (165.4) 122.8 (183.6) 0.642 107.8 (160.0) 100.7 (148.8) 0.855 114.8 (168.9) 134.8 (199.2) 0.491
Skimmed milk (g/d) 96.9 (166.0) 103.9 (182.9) 0.942 84.0 (146.7) 73.0 (144.1) 0.292 104.7 (176.5) 120.8 (199.0) 0.434
Condensed milk (g/d) 0.2 (2.2) 0.2 (2.0) 0.311 0.1 (1.1) 0.1 (0.8) 0.589 0.2 (2.7) 0.3 (2.5) 0.639
Total milk (g/d) 255.4 (181.9) 260.2 (199.0) 0.856 237.3 (162.0) 215.4 (174.4) 0.125 266.3 (192.5) 284.5 (207.4) 0.468
Whole-fat yoghurt (g/d) 21.2 (52.4) 21.4 (56.5) 0.541 26.8 (60.3) 18.7 (49.7) 0.204 17.8 (46.8) 22.8 (60.0) 0.818
Skimmed yoghurt (g/d) 39.4 (60.9) 55.0 (82.1) 0.004 29.2 (54.6) 41.9 (69.7) 0.150 45.6 (63.7) 62.1 (87.4) 0.016
Skimmed milk and yoghurt (g/d) 248.5 (200.6) 317.6 (239.2) 0.053 221.0 (185.6) 215.6 (184.9) 0.762 265.1 (207.9) 317.6 (239.2) 0.014
Whipped cream (g/d) 0.2 (1.2) 0.4 (4.6) 0.305 0.2 (1.0) 0.8 (7.4) 0.699 0.2 (1.3) 0.3 (1.5) 0.321
Milkshake (g/d) 0.9 (10.0) 1.4 (15.3) 0.478 1.3 (14.1) 0.8 (6.7) 0.259 0.6 (6.3) 1.8 (18.4) 0.975
Ricotta cheese or junket (g/d) 1.5 (8.4) 1.4 (8.0) 0.378 1.4 (6.7) 1.4 (8.6) 0.991 1.6 (9.2) 1.4 (7.6) 0.268
Petit Suisse cheese (g/d) 0.6 (4.8) 0.3 (3.0) 0.717 0.0 (0.0) 0.0 (0.0) 0.980 0.9 (6.1) 0.4 (3.5) 0.927
Spreadable cheese wedges (g/d) 0.9 (2.7) 1.4 (4.8) 0.646 1.1 (3.1) 1.2 (4.1) 0.602 0.8 (2.5) 1.5 (5.1) 0.323
Cottage cheese (g/d) 13.0 (14.4) 15.7 (20.2) 0.101 9.5 (11.1) 12.6 (17.9) 0.296 15.1 (15.7) 17.4 (21.2) 0.274
Other cheese (hard cheese) (g/d) 16.1 (18.1) 14.8 (14.5) 0.739 18.0 (18.2) 16.0 (13.6) 0.706 15.0 (18.0) 14.1 (14.9) 0.914
Custard (g/d) 3.1 (11.9) 2.5 (8.8) 0.615 3.7 (13.4) 3.5 (11.5) 0.324 2.8 (10.9) 2.0 (6.9) 0.805
Ice cream (g/d) 1.8 (4.7) 3.2 (14.8) 0.873 1.9 (3.7) 4.5 (21.2) 0.966 1.8 (5.3) 2.4 (9.7) 0.755
Lactose (g/d) 14.4 (9.2) 15.1 (10.4) 0.441 13.4 (8.3) 12.6 (9.1) 0.311 15.0 (9.6) 16.5 (10.9) 0.115
SD: Standard deviation
P values for the comparison of means between CC and CT+TT subjects for dairy products were carried out by the non-parametric Mann-Whitney U test
CCCC CT+TT
LNP (n=133) LP (n=205)
WomenWhole population Men
LNP (n=283)
CC
LNP (n=357) LP (n=583) LP (n=378)
CT+TTCT+TT
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Table 3: Association of the LCT rs4988235 polymphism with anthropometric variables in the
elderly Mediterranean population
    Mean   (SD)    Mean   (SD) P1 P2 P3
Age (years) 67.5 (6.1) 66.8 (6.1) 0.080
Height (m) 1.59 (0.08) 1.59 (0.08) 0.392 0.314 0.333
Weight (Kg) 75.2 (12.3) 76.8 (11.7) 0.044 0.032 0.021
BMI (Kg/m2) 29.7 (4.2) 30.6 (4.2) 0.003 0.004 0.002
Waist circumference (cm) 101.1 (11.8) 103.5 (11.5) 0.005 0.002 0.002
Obesity prevalence (%) 0.014
OR for obesity and (95% CI) 1.39 (1.07-1.82) 0.014
1.39 (1.06-1.81) 0.017
1.37 (1.03-1.81) 0.029
SD: Standard deviation
P1: Unadjusted P value
P2: Model adjusted for sex and age
P3: Model adjusted for sex, age, diabetes, total energy intake and physical activity
45.4
1 (reference)
53.7
CC
LNP (n=357) LP (n=583)
CT+TT
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Table 4: Association of the LCT rs4988235 polymphism with plasma lipids, 
glucose, and blood pressure. Adjusted means*
Mean   (SE) Mean   (SE) P
Total cholesterol (mg/dL) 206.6 (2.2) 204.4 (1.8) 0.418
LDL-C (mg/dL) 129.67 (2.09) 127.10 (1.64) 0.324
HDL-C (mg/dL) 51.3 (0.7) 52.1 (0.6) 0.349
Triglycerides (mg/dL)) 136.7 (4.6) 129.3 (3.6) 0.198
Fasting glucose (mg/dL)** 121.3 (1.8) 121.7 (1.4) 0.868
Systolic blood pressure (mm Hg) 146.3 (1.2) 147.4 (0.9) 0.422
Diastolic blood pressure (mm Hg) 81.7 (0.7) 82.6 (0.5) 0.309
SE: Standard error
*Means were adjusted for sex, age and BMI
**: Means were additionally adjusted for diabetes
CC
LNP (n=357) LP (n=583)
CT+TT
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LEGENDS TO FIGURES 
 
Figure 1: Modulation by dairy lactose intake of the association between the LCT -13910C>T 
polymorphism and waist circumference (cm) in the elderly Mediterranean population: Panel A, 
predicted values of waist circumference by the LCT -13910C>T (n=357 CC individuals and 
n=576 T-allele carriers (8 outliers with lactose intake higher than 50 g/d were removed to 
improve normality for the statistical analysis) depending on the lactose consumed (as continuous) 
are depicted. Predicted values were calculated from the regression models containing lactose 
intake, the LCT polymorphism, their interaction term, and the potential confounders [sex, age (as 
continuous), diabetes (as categorical), total energy intake (as continuous) and physical activity (as 
continuous]. Predicted values for this model were obtained for each individual. The P value for 
the interaction term was obtained in the multivariate interaction model. Panel B represents 
adjusted means of waist circumference (cm) in the study subjects (n=940) depending on the LCT 
-13910C>T polymorphism according to 3 strata of lactose intake: low [<=8 g lactose/d; 20% of 
the population (n=68 CC, 122 CT+TT)], intermediate [ 8-24 g lactose/d; 50% of the population 
(n=188 CC, 284 CT+TT)], and high [>24 g lactose/d; 30% of the population (n=101 CC, 177 
CT+TT)]. Estimated means were adjusted for sex, age (as continuous), diabetes (as categorical), 
total energy intake (as continuous) and physical activity (as continuous). P values for genotype 
comparisons in each strata were estimated after multivariate adjustment for the covariates 
indicated above. Bars indicate standard error (SE) of means. 
Page 26 of 27
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901
Obesity
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 27 
Fig 1 
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